Skip to main content
Year archive

Xvivo Perfusion — 2022 filings

All 30 regulatory filings released by Xvivo Perfusion (XVIVO) in 2022, sourced directly from the official regulator.

30 Filings
2022 Period
2022 filings (30)
Filing Released Lang
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2022-12-30 Swedish
Increased number of shares and votes in XVIVO Perfusion AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2022-12-30 English
Christoffer Rosenblad utsedd till VD i XVIVO
Board/Management Information
2022-11-30 Swedish
Christoffer Rosenblad appointed as CEO of XVIVO
Board/Management Information
2022-11-30 English
XVIVO slutför förvärvet av maskin- och perfusionsverksamheten från Avionord S.r.l.
Share Issue/Capital Change
2022-11-30 Swedish
XVIVO completes the acquisition of the machine and perfusion business from Avionord S.r.l.
Share Issue/Capital Change
2022-11-30 English
Interim / Quarterly Report 2022
Interim / Quarterly Report 9M 2022
2022-10-27 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report 9M 2022
2022-10-27 English
XVIVO Perfusions vd Dag Andersson har avlidit
Board/Management Information
2022-09-27 Swedish
XVIVO Perfusion's CEO Dag Andersson has passed away
Board/Management Information
2022-09-27 English
XVIVO presenterar strategi för 2023-2027 på kapitalmarknadsdagen
Regulatory Filings
2022-09-21 Swedish
XVIVO presents strategy for 2023-2027 at its Capital Markets Day
Investor Presentation
2022-09-21 English
XVIVO enters into an agreement to acquire its Italian distributor - securing a unique business model
M&A Activity
2022-08-01 English
XVIVO ingår avtal om att förvärva sin italienska distributör - säkrar en unik affärsmodell
M&A Activity
2022-08-01 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report H1 2022
2022-07-13 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report H1 2022
2022-07-13 English
Change in number of shares and votes in XVIVO Perfusion
Share Issue/Capital Change
2022-06-30 English
Förändring av antalet aktier och röster i XVIVO Perfusion
Declaration of Voting Results & Voting Rights Announcements
2022-06-30 Swedish
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
AGM Information
2022-04-26 English
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
AGM Information
2022-04-26 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Q1 2022
2022-04-25 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Q1 2022
2022-04-25 English
Annual Report (ESEF) 2021
Annual Report (ESEF) FY 2021
2022-04-04 Swedish
Annual Report (ESEF) 2021
Annual Report (ESEF) FY 2021
2022-04-04 Swedish
XVIVO får sitt första certifikat enligt EUs förordning Medical Device Regulation (MDR) för Kidney Assist Transport
Regulatory Filings
2022-03-23 Swedish
XVIVO obtains its first certificate under EU Medical Device Regulation (MDR) for Kidney Assist Transport
Regulatory Filings
2022-03-23 English
Earnings Release 2021
Earnings Release Q4 2021
2022-01-27 Swedish
Earnings Release 2021
Earnings Release Q4 2021
2022-01-27 English
XVIVOs Kidney Assist Transport får 510(k)-godkännande av amerikanska FDA och blir XVIVOs första regulatoriskt godkända produkt för transplantation av abdominala organ i USA
Regulatory Filings
2022-01-21 Swedish
XVIVO’s Kidney Assist Transport receives 510(k) clearance by US FDA, which is XVIVO’s first regulatory cleared product for abdominal transplantation in the US
Regulatory Filings
2022-01-21 English